Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-060706
Filing Date
2017-11-14
Accepted
2017-11-14 17:52:40
Documents
1
Period of Report
2017-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15880
  Complete submission text file 0001209191-17-060706.txt   17270
Mailing Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Engelhart James (Reporting) CIK: 0001704255 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38080 | Film No.: 171203306